This 2017 Clinical Research Forum Top Ten Clinical Research Achievement Award-winning study, led by Dr. Mark Genovese of Stanford University School of Medicine, looked at a new drug for rheumatoid arthritis, and tested it in over 500 patients with hard-to-treat disease. This new drug was found to be safe and effective, significantly improving disease in over 50% of patients within 12 weeks.
